Leaflet GRANDAXIN 50mg tablets


Indicated for: anxiety

Substance: tofisopam (anxiolytic)

ATC: N05BA23 (Nervous system | Anxiolytics | Benzodiazepine derivatives)

Tofisopam is a benzodiazepine-class medication used in the treatment of anxiety disorders and other stress-related conditions. Unlike other benzodiazepines, tofisopam has a unique profile, providing anxiolytic effects without significant sedation or dependency.

Tofisopam is administered orally, usually two or three times daily, with the dose adjusted based on the severity of symptoms and the patient's response. It is indicated for patients who require anxiety reduction without impairing cognitive or motor functions.

Common side effects include nausea, dizziness, headache, and gastric discomfort. In rare cases, severe adverse reactions such as allergic reactions or liver function impairment may occur. Regular monitoring of the patient's condition is essential during treatment.

Tofisopam is an effective and well-tolerated therapeutic option for managing anxiety, contributing to improved quality of life for patients.

General data about GRANDAXIN 50mg

  • Substance: tofisopam
  • Date of last drug list: 01-04-2014
  • Commercial code: W05938001
  • Concentration: 50mg
  • Pharmaceutical form: tablets
  • Quantity: 20
  • Product type: original
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).